orthobiologics
-
Biologics
Orthobiologics Market Is Expected To Reach a Revenue Of USD 11.7 Bn By 2033, at 5.7% CAGR: Dimension Market Research
Advancements and Projections in the Orthobiologics Market: Insights, Trends, Opportunities, and Recent Developments New York, Nov. 11, 2024 (GLOBE NEWSWIRE)…
Read More » -
Top Stories
Xenco Medical Unveils the TrabeculeX Continuum, a Breakthrough Convergence of Digital Health and Biomaterials
January 16, 2024 – OrthoSpineNews –Trailblazing medical technology company Xenco Medical has unveiled TrabeculeX Continuum, a novel convergent technology bridging…
Read More » -
Biologics
Xtant Medical Highlights Growing Product Portfolio at NASS 2023
BELGRADE, Mont., Oct. 12, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Biologics
Orthobiologics Market Size to Hit USD 12.2 Billion by 2030 at 7.2% CAGR – Report by Market Research Future (MRFR)
Orthobiologics Market Trends and Insights By Product (Demineralized Bone Matrix and Bone Morphogenetic Protein), By Application (Osteoarthritis & Degenerative Arthritis…
Read More » -
Biologics
Induce Biologics Announces Launch of NMP Cancellous Strips
Launch is an extension to the company’s Natural Matrix Protein (NMP) family of products TAMPA, Fla., February 28, 2023 /…
Read More » -
Biologics
Orthobiologics Market to Surpass US$ 10,300.6 Million by 2030, Says Coherent Market Insights (CMI)
Burlingame, Feb. 20, 2023 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global orthobiologics market is estimated to be valued at US$ 6,515.2 in 2022 and is…
Read More » -
Biologics
Orthobiologics market size to increase by USD 2,638.44 million: North America will account for 41% of market growth – Technavio
NEW YORK, Jan. 24, 2023 /PRNewswire/ — The orthobiologics market by product and geography – forecast and analysis 2023-2027 report has been published by…
Read More » -
Biologics
Global Orthobiologics Market valued at $5.4 billion in 2021, is expected to witness a decent growth rate of 7% in the next 5 years
Medi-Tech Insights: Growing cases of sports injuries and road accidents, increasing geriatric and obese population globally, rising number of people…
Read More » -
Financial
Global Orthobiologics Market to Generate Revenue of $6.91 billion by 2028 – SkyQuest Technology
Global orthobiologics market was valued at US$ 5.01 billion in 2021, and it is expected to reach a value of…
Read More » -
Biologics
Orthobiologics Market is Forecast to Touch USD 8.8 Billion Grow at a CAGR of 5.20% by 2028 | BlueWeave Consulting
North America dominates the orthobiologics market owing to the developed healthcare infrastructure and high adoption of advanced treatment methods in…
Read More » -
Biologics
Orthobiologics Market | Exclusive Report on the Latest Revenue and Future Scope – MDC Research
North America will continue to dominate the global market in the forecast period owing to factors such as growing need…
Read More » -
Biologics
SeaSpine® Announces Full Commercial Launch of NorthStar™ Facet Fusion and Limited Commercial Launch of FLASH™ Navigation Lumbar Facet Fusion
CARLSBAD, Calif., March 01, 2022 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Biologics
Kuros Biosciences Further Strengthens Orthobiologics Patent Portfolio
SCHLIEREN (ZURICH), Switzerland, July 22, 2020 (GLOBE NEWSWIRE) — Kuros Biosciences (SIX: KURN) today announced that its Dutch subsidiary, Kuros…
Read More » -
Biologics
Orthobiologics Market for Bone Repair & Regeneration, 2018-2024 – Dominated by Medtronic, MTF Biologics, NuVasive, and Orthofix
DUBLIN, April 15, 2020 /PRNewswire/ — The “Orthobiologics for Bone Repair and Regeneration” report has been added to ResearchAndMarkets.com offering. Over the forecast period…
Read More » -
Biologics
Acumed Signs Agreement with Vivorte to Distribute its Orthobiologics Portfolio
HILLSBORO, OREGON (PRWEB) MARCH 13, 2020 Acumed LLC today announced that it has entered into an agreement with Vivorte Inc. to…
Read More »